Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, National University of Singapore Ink Life Sciences MOU

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and the National University of Singapore today announced the signing of a memorandum of understanding to develop a strategic alliance to increase advance basic and applied research in Singapore.

The agreement covers the life sciences, healthcare, and applied markets, and includes cancer and diagnostics. Thermo Fisher and NUS will develop analytical technologies, reagents, instruments, and software, they said.

As part of the deal, Thermo Fisher will, for up to five years, sponsor short-term and multiyear research grants in the life sciences and will support collaborations with NUS, including a joint symposium to advance the exchange of scientific knowledge in the biological and physical sciences.

Financial and other details of the deal were not disclosed.

A year ago, the partners announced a collaboration with NUS' Environmental Research Institute to conduct metabolomic research into the water systems around Singapore.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.